Trichosanthin enhances the antitumor effect of gemcitabine in non‑small cell lung cancer via inhibition of the PI3K/AKT pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trichosanthin enhances the antitumor effect of gemcitabine in non‑small cell lung cancer via inhibition of the PI3K/AKT pathway

Published:2017-10-11 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Tuya Naren¹,Wang Yadi¹,Tong Lanmei²,Gao Weishi²,Yu Rong³,Xue Liying²

Affiliation:

1. Department of Biology, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China

2. Department of Chemotherapy Oncology, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia 010020, P.R. China

3. Department of Radiation Oncology, Inner Mongolia Cancer Hospital, Hohhot, Inner Mongolia 010020, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

2. Gemcitabine resistance in non‐small cell lung cancer is mediated through activation of the PI3K/AKT/NF‐κB pathway and suppression of ERK signaling by reactive oxygen species;Journal of Biochemical and Molecular Toxicology;2023-08-11

3. Ribosome-Directed Therapies in Cancer;Biomedicines;2022-08-26

4. The Ethanolic Extract of Trichosanthes Kirilowii Root Exerts anti-Cancer Effects in Human Non-Small Cell Lung Cancer Cells Resistant to EGFR TKI;Nutrition and Cancer;2022-08-25

5. Guanxinping Tablets Inhibit ET-1-Induced Proliferation and Migration of MOVAS by Suppressing Activated PI3K/Akt/NF-κB Signaling Cascade;Evidence-Based Complementary and Alternative Medicine;2022-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3